Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

Tarsus Pharmaceuticals Inc (TARS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Tarsus's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.81 +1.99    +5.13%
01/08 - Closed. Currency in USD
After Hours
41.62
+0.80
+1.96%
21:36:21 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,062,695
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 38.51 - 40.96
Tarsus 40.81 +1.99 +5.13%

TARS Recent Sentiments

 
This page features our user's sentiments regarding the Tarsus Pharmaceuticals Inc share. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Jul 23, 2025 Khaled Lamloum   42.43 -3.82%
May 21, 2025 めい せい   45.69 May 26, 2025 @ 42.98 -5.93%
May 12, 2025 めい せい   44.69 May 19, 2025 @ 44.13 -1.25%
May 05, 2025 Donald Hopkins   48.03 May 30, 2025 @ 42.97 -10.54%
Mar 17, 2025 めい せい   47.43 Mar 24, 2025 @ 50.02 +5.46%
Feb 27, 2025 めい せい   42.78 Mar 03, 2025 @ 42.86 +0.19%
Jan 24, 2025 めい せい   49.12 Jan 27, 2025 @ 53.05 +8.00%
Jan 16, 2025 めい せい   44.20 Jan 20, 2025 @ 46.52 +5.25%
Jan 07, 2025 めい せい   54.68 Jan 13, 2025 @ 48.33 -11.61%
Dec 16, 2024 Мерис Мерис   51.80 Jan 10, 2025 @ 52.60 +1.54%
Dec 09, 2024 めい せい   49.70 Dec 09, 2024 @ 50.00 +0.60%
Dec 06, 2024 S S   52.50 Dec 09, 2024 @ 50.00 -4.76%
Nov 25, 2024 めい せい   48.24 Nov 25, 2024 @ 48.36 +0.25%
Nov 12, 2024 S S   49.08 Nov 18, 2024 @ 46.47 -5.32%
Oct 28, 2024 ESSA ALOOMY   47.78 Nov 04, 2024 @ 46.70 -2.26%
Sep 23, 2024 Miguel Torre   34.51 Sep 23, 2024 @ 33.80 -2.06%
Aug 29, 2024 S S   27.98 Sep 02, 2024 @ 27.11 -3.11%
Aug 12, 2024 Miguel Torre   26.63 Aug 19, 2024 @ 26.27 -1.35%
Jul 29, 2024 Maria Rayfshnayder   24.59 Aug 23, 2024 @ 25.53 -3.82%
Feb 26, 2024 דקל ענאקי   27.00 Mar 04, 2024 @ 37.77 +39.89%
Feb 23, 2024 Bernd Kirstner   31.96 Feb 26, 2024 @ 32.23 +0.84%
Feb 12, 2024 Rozi Dor   30.49 Feb 12, 2024 @ 31.49 +3.28%
Nov 20, 2023 Özgür Açıkbaş   18.86 Nov 30, 2023 @ 16.47 -12.67%
Oct 18, 2023 Birl Schilling   13.37 Nov 30, 2023 @ 16.47 -23.19%
Jul 20, 2023 Orhan Suvak   22.28 Nov 30, 2023 @ 16.47 -26.08%
Jul 20, 2023 Barış Uzun   21.69 Nov 30, 2023 @ 16.47 -24.07%
Dec 03, 2021 Tuncay ALTUNTAŞ   24.82 Dec 24, 2021 @ 25.93 -4.47%
Oct 19, 2021 Khalid Al Zarooni   28.30 Nov 12, 2021 @ 27.42 -3.11%
Jun 22, 2021 Aashish Kamthan   28.46 Jul 16, 2021 @ 25.39 -10.79%
Apr 16, 2021 Arman Kala   28.24 May 07, 2021 @ 29.98 -6.16%
Jan 20, 2021 Patrick Mäter   42.40 Feb 12, 2021 @ 37.16 -12.36%
Dec 21, 2020 쮸쀼 쮸쀼   42.89 Jan 15, 2021 @ 43.17 +0.65%
Dec 18, 2020 Alberto Bassi   58.93 Jan 08, 2021 @ 44.78 -24.01%
Dec 08, 2020 Inez Oberg   30.50 Jan 01, 2021 @ 41.33 +35.51%
Nov 25, 2020 Sebastian Puchalski   20.90 Dec 18, 2020 @ 49.62 -137.42%
Nov 13, 2020 Javier Cervera   23.78 Dec 04, 2020 @ 24.90 +4.71%
Nov 05, 2020 Lesley van Dijk   25.83 Nov 11, 2020 @ 21.19 -17.96%
Oct 16, 2020 Onur Kutlu   0.00 Oct 16, 2020 @ 0.00 0.00%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TARS Comments

Write your thoughts about Tarsus Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email